These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5548486)

  • 1. The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor).
    Ogston D; Bennett NB; Ogston CM; Ratnoff OD
    Br J Haematol; 1971 Feb; 20(2):209-16. PubMed ID: 5548486
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.
    Ogston D; Ogston CM; Ratnoff OD; Forbes CD
    J Clin Invest; 1969 Oct; 48(10):1786-801. PubMed ID: 4241814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
    Herold R; Straub PW
    J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
    [No Abstract]   [Full Text] [Related]  

  • 5. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
    Kaplan AP; Austen KF
    J Exp Med; 1972 Dec; 136(6):1378-93. PubMed ID: 4264575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hageman factor as plasminogen plasma activator].
    Januszko T; Buluk K
    Pol Arch Med Wewn; 1968; 40(2):197-203. PubMed ID: 5669680
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
    Iatridis PG; Gadarowski JJ; Iatridis SG
    Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
    Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
    J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.
    Kaplan AP; Goetzl EJ; Austen KF
    J Clin Invest; 1973 Oct; 52(10):2591-5. PubMed ID: 4729052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
    Kluft C; Wijngaards G; Jie AF
    J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAGEMAN FACTOR IN THE FIBRINOLYTIC SYSTEM.
    AZNAR J; LOPEZ-BORRASCA A
    Lancet; 1965 Feb; 1(7382):437-8. PubMed ID: 14238112
    [No Abstract]   [Full Text] [Related]  

  • 13. A plasminogen proactivator-activator system in human blood effective in absence of Hageman Factor.
    Astrup T; Rosa AT
    Thromb Res; 1974 Apr; 4(4):609-13. PubMed ID: 4428468
    [No Abstract]   [Full Text] [Related]  

  • 14. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
    Kaplan AP; Austen KF
    J Exp Med; 1971 Apr; 133(4):696-712. PubMed ID: 4251126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
    Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma inhibitors of the Hageman factor dependent pathways.
    Schreiber AD
    Semin Thromb Hemost; 1976 Jul; 3(1):32-51. PubMed ID: 799348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic properties of the Hageman factor. (Thromboelastographical study)].
    AZNAR J; LOPEZ BORRASCA A; CALATAYUD R; BARATA JJ
    Rev Clin Esp; 1963 Jun; 89():276-81. PubMed ID: 13965764
    [No Abstract]   [Full Text] [Related]  

  • 18. HAGEMAN FACTOR AND IN VIVO ACTIVATION OF FIBRINOLYSIS.
    HOLEMANS R; ROBERTS HR
    J Lab Clin Med; 1964 Nov; 64():778-86. PubMed ID: 14226397
    [No Abstract]   [Full Text] [Related]  

  • 19. Technical remarks on the microscopical demonstration of tissue plasminogen activator.
    Pandolfi M; Bjernstad A; Nilsson IM
    Thromb Diath Haemorrh; 1972 Feb; 27(1):88-98. PubMed ID: 5033673
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP; Ferguson JH
    Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.